Law School Alumna Wins National Book Award

Annette Gordon-Reed’s book on a slave family owned by Thomas Jefferson takes the nonfiction prize.

This year’s National Book Award for nonfiction went to The Hemingses of Monticello: An American Family, by Annette Gordon-Reed, J.D. ’84.

The book follows three generations of a slave family owned by Thomas Jefferson. It beat out This Republic of Suffering—University president Drew Faust’s account of the Civil War’s staggering death toll and how it changed Americans’ view of death—which was also a finalist in the nonfiction category. (Read an excerpt from Faust’s book in the Harvard Magazine archives.)

Other finalists with Harvard connections included Joan Wickersham, author of this magazine’s 2007 cover story “Bricks and Politics: What gets built at Harvard, what doesn’t, and why,” a nonfiction nominee for her memoir, The Suicide Index: Putting My Father’s Death in Order; and Frank Bidart, A.M. ’67, nominated for his book of poems, Watching the Spring Festival.

To learn more, read the New York Times account, or visit the National Book Foundation website.

Most popular

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

The University has pushed the adoption of AI into teaching and operations, but faculty resistance is growing louder.

In 1954, Gregory Corso moved into Eliot House. How he stayed there is a literary legend.

Explore More From Current Issue

Colorful cartoon animals, including dogs, cows, rabbits, and a fence, on a pink background.

Inseparable cows, big dogs fostering a tiny kitten, and a show beagle’s second act

A football player in a white jersey evades a defender in a green uniform on the field.

Despite personnel losses, Crimson captain Xaviah Bascon is upbeat about the 2026 season.

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.